Series B funding round for Inversago Pharma raising $35M in September 2020
Series B funding round for Inversago Pharma raising $35M in September 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Ed Mathers |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$111M
Top Valuation
-
Inversago Pharma raised $35M in a Series B round.
The round was announced on 09/01/20.